Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- NKF Survey Sheds Light on Work Responsibilities and More Posted 07-16-2026
- Home HD Now Offered in Croatia Posted 07-16-2026
- See interviews with 17 Influential Nephrology and Dialysis Pioneers Posted 07-16-2026
- H.R. 8376 Would Require Medicare to Cover Palliative PD or Home HD Posted 06-17-2026